Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

Mitral regurgitation is the most common form of valvular heart disease and affects around 10% of Americans over 75. It occurs when the mitral ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

The Cardiac Dimensions Carillon Mitral Contour System is a minimally invasive mitral regurgitation therapy made possible by ...

Functional mitral valve regurgitation occurs when the left atrium or left ventricle dilates, causing the mitral valve annulus to also dilate and prevent the mitral valve leaflets from properly ...

Life became increasingly difficult for those patients who were facing chronic heart problems. Mitral valve leakage or regurgitation is the most common valvular heart disease. With a global ...

The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the patient's heart.

Mitral regurgitation is the abnormal backward flow of blood from the left ventricle (LV) to the left atrium (LA) due to disease of the mitral valve apparatus (primary MR) or due to dilation of the ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful ...

Find effective medications for 'Mitral Valve Regurgitation and Mitral Valve Replacement treatment right here!' This page is a trusted source for both professionals and patients, detailing brand ...